Certification Introduction
To place medical devices on the Malaysian market or export medical devices to Malaysia, completion of registration and certification with the Malaysian Medical Device Authority (MDA) is mandatory. MDA is the only official authority in Malaysia responsible for medical device regulation and registration review. MDA classifies medical devices into four risk-based classes (A, B, C, D), with stricter review requirements corresponding to higher risk levels. Starting March 2026, Malaysia has achieved mutual recognition of medical device regulation with Singapore, and had previously established mutual recognition pilot arrangements with China and Thailand. The compliance process is continuously simplified, and eligible products already approved by other authoritative regulators can access the simplified registration pathway.
Laws and Regulations
The core regulatory basis is the Malaysian Medical Device Act (Act 737). In 2025, MDA updated new regulations on medical device classification, fully implemented the risk-based classification regulatory system, and launched the electronic registration system MedCAST to accept applications uniformly. MDA promotes international regulatory mutual recognition arrangements, and recognizes approval results from mainstream regulatory authorities including EU CE, US FDA and Australian TGA, which can be used to simplify the registration process. The specific scope of mutual recognition shall be subject to the latest announcement on MDA's official website.
Technical Requirements
- The quality management system shall comply with the requirements of ISO 13485, and risk management shall comply with ISO 14971.
- Complete technical documentation shall be prepared, including product description, design and development information, safety performance test data, risk analysis report, verification and validation documents, and labels and instructions for use that meet local requirements.
- Class C and D high-risk medical devices shall provide a compliant clinical evaluation report or clinical trial data.
- Labeling shall comply with MDA's labeling specifications, and content descriptions in the corresponding official language shall be provided.
Certification Process
First, complete product risk classification to confirm the corresponding certification path; then prepare a full set of application materials including technical documentation and quality management system certificates; a Conformity Assessment Body (CAB) recognized by MDA will complete the product conformity assessment and issue a certificate of conformity; then submit the registration application and relevant supporting materials via MDA's official online system MedCAST; MDA will conduct review, and may request supplementary materials or carry out on-site inspections depending on the product risk level; after passing the review, you will obtain MDA registration approval and the product can be officially launched on the market, and post-market adverse event monitoring and post-market surveillance shall be implemented as required after launch.
WANVE, as a professional technical service organization, provides one-stop full compliance support for enterprise export.